Login / Signup

A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naïve or opioid-resistant patients.

Ji Yoon JungHong Jae ChonYoung Jin ChoiSang Eun YeonSeok Young ChoiKyung Hee Lee
Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)
This study showed that tapentadol ER was effective for treating patients with moderate to severe cancer pain and neuropathic pain, and therefore it significantly improved the patients' QoL.
Keyphrases